Tech Company Financing Transactions
BioAegis Therapeutics Funding Round
BioAegis Therapeutics, based in North Brunswick, secured $3.7 million from private investors.
Transaction Overview
Company Name
Announced On
2/10/2014
Transaction Type
Debt
Amount
$3,732,412
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
675 US Hwy. 1
North Brunswick, NJ 08192
USA
North Brunswick, NJ 08192
USA
Phone
Website
Email Address
Overview
BioAegis Therapeutics develops novel protein replacement therapies targeted at saving lives based on the endogenous human protein, plasma gelsolin (pGSN).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Thomas Stossel
Chief Executive Officer
Susan Levinson
Chief Medical Officer
Mark DiNubile
Chief Operating Officer
Valerie Ceva
Browse more venture capital transactions:
Prev: 2/10/2014: CoPromote venture capital transaction
Next: 2/10/2014: Abe's Market venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs